 |
27 Diseases |  |
22 Trials |
|
22 Trials |  |
341 News |  |
| «1234567 |
- | bupropion sustained-release / Generic mfg.
New P2 trial: Bupropion for Smoking Cessation in Pregnancy (clinicaltrials.gov) - Jun 9, 2013
P2, N=135, Completed, Sponsor: Watching Over Mothers & Babies Foundation
- ||||||| Chantix (varenicline) / Pfizer
Trial completion, Combination therapy: Varenicline and Bupropion for Smoking Cessation (clinicaltrials.gov) - Apr 15, 2013
P2/3, N=506, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Trial termination, Surgery: SWOG-S0002: S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery (clinicaltrials.gov) - Mar 7, 2013
P3, N=10, Terminated, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Completed --> Terminated; This study was closed early due to poor accrual
- Chantix (varenicline) / Pfizer
Trial completion: Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts (clinicaltrials.gov) - Feb 13, 2013
P4, N=923, Completed, Sponsor: Centre for Addiction and Mental Health
Completed --> Terminated; This study was closed early due to poor accrual Active, not recruiting --> Completed
- ||||| bupropion sustained-release / Generic mfg.
Enrollment closed: Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (clinicaltrials.gov) - Feb 7, 2013
P3, N=240, Active, not recruiting, Sponsor: Orexigen Therapeutics, Inc
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Trial completion: VSCS: Varenicline and Smoking Cessation in Schizophrenia (clinicaltrials.gov) - Feb 4, 2013
P2, N=60, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New P1 trial: Influence of Bupropion on the Effects of MDMA (clinicaltrials.gov) - Jan 16, 2013
P1, N=16, Completed, Sponsor: University Hospital, Basel, Switzerland
- |||||||||| bupropion sustained-release / Generic mfg.
New P3 trial: Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (clinicaltrials.gov) - Jan 7, 2013
P3, N=240, Active, not recruiting, Sponsor: Orexigen Therapeutics, Inc
- | aripiprazole / Generic mfg., bupropion sustained-release / Generic mfg.
Enrollment open: VAST-D: VA Augmentation and Switching Treatments for Improving Depression Outcomes (clinicaltrials.gov) - Dec 16, 2012
P3, N=1518, Recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Empatic (bupropion SR/zonisamide SR) / Currax
Enrollment change, Combination therapy, Monotherapy: Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity (clinicaltrials.gov) - Nov 26, 2012
P2b, N=729, Completed, Sponsor: Orexigen Therapeutics, Inc
Not yet recruiting --> Recruiting N=600 --> 729
- ||||||| bupropion sustained-release / Generic mfg.
Trial completion: A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD) (clinicaltrials.gov) - Oct 31, 2012
P3, N=572, Completed, Sponsor: GlaxoSmithKline
N=600 --> 729 Recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Trial completion: Bupropion and Weight Control for Smoking Cessation - 1 (clinicaltrials.gov) - Sep 3, 2012
P4, N=349, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed Active, not recruiting --> Completed
- Aplenzin (bupropion hydrobromide ER) / Bausch Health
Biomarker, Enrollment change: Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial. (clinicaltrials.gov) - Aug 20, 2012
P4, N=36, Completed, Sponsor: Stanford University
Active, not recruiting --> Completed N=120 --> 36
- Aplenzin (bupropion hydrobromide ER) / Bausch Health
Biomarker, Trial completion: Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial. (clinicaltrials.gov) - Aug 20, 2012
P4, N=36, Completed, Sponsor: Stanford University
N=120 --> 36 Enrolling by invitation --> Completed
- Chantix (varenicline) / Pfizer
Enrollment change: ChanBan: Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence (clinicaltrials.gov) - Jul 8, 2012
P2/3, N=10, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Enrolling by invitation --> Completed N=48 --> 10
- Chantix (varenicline) / Pfizer
Trial completion: ChanBan: Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence (clinicaltrials.gov) - Jul 8, 2012
P2/3, N=10, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
N=48 --> 10 Recruiting --> Completed
- Chantix (varenicline) / Pfizer
Enrollment closed: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Jul 4, 2012
P2, N=60, Active, not recruiting, Sponsor: Yale University
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Chantix (varenicline) / Pfizer
Enrollment open: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Jun 28, 2012
P4, N=8000, Recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial completion: Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning (clinicaltrials.gov) - Jun 26, 2012
P4, N=80, Completed, Sponsor: Weill Medical College of Cornell University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
Enrollment change: Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers (clinicaltrials.gov) - Jun 18, 2012
P4, N=125, Completed, Sponsor: Southern Illinois University Carbondale
Active, not recruiting --> Completed N=220 --> 125
- | bupropion sustained-release / Generic mfg.
Trial completion: Maintaining Nonsmoking: Older Smokers - 1 (clinicaltrials.gov) - Jun 17, 2012
P3, N=403, Completed, Sponsor: University of California, San Francisco
N=220 --> 125 Active, not recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New P4 trial: Bupropion SR Plus Counseling for Smoking Cessation (clinicaltrials.gov) - Jun 13, 2012
P4, N=0, Completed, Sponsor: University of Wisconsin, Madison
- Chantix (varenicline) / Pfizer
Enrollment open: Tailored Tobacco Quitline for Rural Veterans (clinicaltrials.gov) - Jun 11, 2012
P2, N=50, Enrolling by invitation, Sponsor: University of Iowa
Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- bupropion sustained-release / Generic mfg.
Clinical: Behavioral Maintenance Treatment for Smoking Cessation (clinicaltrials.gov) - Jun 7, 2012
P=N/A, N=304, Completed, Sponsor: Stanford University
- Chantix (varenicline) / Pfizer
New P2 trial: Tailored Tobacco Quitline for Rural Veterans (clinicaltrials.gov) - May 3, 2012
P2, N=50, Enrolling by invitation, Sponsor: University of Iowa
- | bupropion sustained-release / Generic mfg.
Trial completion: Craving, Binge Eating and Obesity (clinicaltrials.gov) - Apr 25, 2012
P2/3, N=61, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting --> Enrolling by invitation Recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New P4 trial: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia (clinicaltrials.gov) - Apr 9, 2012
P4, N=17, Completed, Sponsor: Massachusetts General Hospital
- ||||| Chantix (varenicline) / Pfizer
New P4 trial: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Apr 8, 2012
P4, N=8000, Recruiting, Sponsor: Pfizer
- bupropion sustained-release / Generic mfg., armodafinil / Generic mfg., minocycline extended release / Generic mfg.
Trial withdrawal: Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) (clinicaltrials.gov) - Apr 5, 2012
P1/2, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Not yet recruiting --> Withdrawn
- bupropion sustained-release / Generic mfg., armodafinil / Generic mfg., minocycline extended release / Generic mfg.
Enrollment change: Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) (clinicaltrials.gov) - Apr 5, 2012
P1/2, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Withdrawn N=32 --> 0
- ||||||| Chantix (varenicline) / Pfizer
Trial completion: ConNic3: Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype (clinicaltrials.gov) - Mar 22, 2012
P3, N=606, Completed, Sponsor: Duke University
N=32 --> 0 Recruiting --> Completed
- |||||||||| Chantix (varenicline) / Pfizer
New P2/3 trial: LiveForLife2: Tailored Smoking Cessation Treatment for LIVE FOR LIFE (clinicaltrials.gov) - Mar 20, 2012
P2/3, N=300, Active, not recruiting, Sponsor: Duke University
- | Chantix (varenicline) / Pfizer
Biomarker, Enrollment closed: Pharmacogenetics, Emotional Reactivity and Smoking (clinicaltrials.gov) - Dec 28, 2011
P2/3, N=375, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- bupropion sustained-release / Generic mfg.
Enrollment closed, Real-world evidence, Real-world effectiveness, Real-world: STOP Study: Effectiveness of Zyban in a Clinical Population (clinicaltrials.gov) - Sep 12, 2011
P4, N=750, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || aripiprazole / Generic mfg., bupropion sustained-release / Generic mfg.
New P3 trial: VAST-D: VA Augmentation and Switching Treatments for Improving Depression Outcomes (clinicaltrials.gov) - Aug 18, 2011
P3, N=1518, Recruiting, Sponsor: Department of Veterans Affairs
- bupropion sustained-release / Generic mfg.
Enrollment open: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Aug 9, 2011
P4, N=150, Recruiting, Sponsor: The University of Texas, Galveston
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting